DE602005016141D1 - S-mirtazapin zur behandlung von hitzewallungen - Google Patents

S-mirtazapin zur behandlung von hitzewallungen

Info

Publication number
DE602005016141D1
DE602005016141D1 DE602005016141T DE602005016141T DE602005016141D1 DE 602005016141 D1 DE602005016141 D1 DE 602005016141D1 DE 602005016141 T DE602005016141 T DE 602005016141T DE 602005016141 T DE602005016141 T DE 602005016141T DE 602005016141 D1 DE602005016141 D1 DE 602005016141D1
Authority
DE
Germany
Prior art keywords
hitzewallungen
mirtazapine
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602005016141T
Other languages
English (en)
Inventor
Bernardus B W M M Peeters
Anton Egbert Peter Adang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Organon NV
Original Assignee
Organon NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34929859&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE602005016141(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Organon NV filed Critical Organon NV
Publication of DE602005016141D1 publication Critical patent/DE602005016141D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
DE602005016141T 2004-11-15 2005-11-14 S-mirtazapin zur behandlung von hitzewallungen Active DE602005016141D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP04105778 2004-11-15
PCT/EP2005/055947 WO2006051111A1 (en) 2004-11-15 2005-11-14 S-mirtazapine for the treatment of hot flush

Publications (1)

Publication Number Publication Date
DE602005016141D1 true DE602005016141D1 (de) 2009-10-01

Family

ID=34929859

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602005016141T Active DE602005016141D1 (de) 2004-11-15 2005-11-14 S-mirtazapin zur behandlung von hitzewallungen

Country Status (31)

Country Link
US (4) US20070265245A1 (de)
EP (1) EP1814555B1 (de)
JP (1) JP2008519810A (de)
KR (1) KR20070085470A (de)
CN (2) CN102772414A (de)
AR (1) AR053780A1 (de)
AT (1) ATE439843T1 (de)
AU (1) AU2005303778B2 (de)
BR (1) BRPI0517818A2 (de)
CA (1) CA2587283C (de)
CY (1) CY1110538T1 (de)
DE (1) DE602005016141D1 (de)
DK (1) DK1814555T3 (de)
ES (1) ES2329815T3 (de)
HK (1) HK1104235A1 (de)
HR (1) HRP20090513T1 (de)
IL (1) IL182767A (de)
MX (1) MX2007005827A (de)
MY (1) MY144089A (de)
NO (1) NO20072285L (de)
NZ (1) NZ554858A (de)
PE (1) PE20061051A1 (de)
PL (1) PL1814555T3 (de)
PT (1) PT1814555E (de)
RS (1) RS51138B (de)
RU (1) RU2396957C2 (de)
SI (1) SI1814555T1 (de)
TW (1) TW200631584A (de)
UA (1) UA88655C2 (de)
WO (1) WO2006051111A1 (de)
ZA (1) ZA200703884B (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007002174A2 (en) * 2005-06-27 2007-01-04 N.V. Organon. A method of treatment of hormone depletion induced vasomotor symptoms
US20070129611A1 (en) * 2005-12-06 2007-06-07 University Of North Texas Health Science Center At Fort Worth System, Method and Apparatus for Assessing Menopausal or Post-Hysterectomy Symptoms
MX2008011434A (es) * 2006-03-06 2008-11-18 Organon Nv Metodo mejorado para retirar del tratamiento hormonal los sintomas vasomotores inducidos por eliminación de hormonas.
AU2007324467A1 (en) * 2006-11-22 2008-05-29 N.V. Organon Vaginal delivery system for mirtazapine
US7645750B2 (en) 2006-12-13 2010-01-12 Yung Shin Pharmaceutical Ind. Co., Ltd. Method of treating symptoms of hormonal variations
JP2009018992A (ja) 2007-07-10 2009-01-29 Sumitomo Chemical Co Ltd 光学活性ミルタザピンの製造方法
US8420624B2 (en) 2007-12-04 2013-04-16 Yung Shin Pharm. Ind. Co., Ltd. Methods for treating or preventing symptoms of hormonal variations
EP3261645B1 (de) 2015-02-27 2021-04-28 Dechra Limited Anregung des appetits, verwaltung von gewichtsverlust und behandlung von anorexie bei hunden und katzen
CA3065003A1 (en) * 2017-05-25 2018-11-29 Glytech, Llc Formulations for treatment of post-traumatic stress disorder

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL189199C (nl) * 1975-04-05 1993-02-01 Akzo Nv Werkwijze ter bereiding van farmaceutische preparaten met werking op het centraal zenuwstelsel op basis van benz(aryl)azepinederivaten, de verkregen gevormde farmaceutische preparaten, alsmede werkwijze ter bereiding van de toe te passen benz(aryl)azepinederivaten.
US4515792A (en) * 1982-09-30 1985-05-07 Ciba-Geigy Corporation Tetracyclic heterocycles and antidepressant compositions thereof
JPH1187727A (ja) * 1997-09-12 1999-03-30 Mitsubishi Electric Corp 半導体装置
ATE254918T1 (de) * 1998-04-02 2003-12-15 Akzo Nobel Nv Orale flüssige lösung enthaltend das antidepressivum mirtazapine

Also Published As

Publication number Publication date
IL182767A (en) 2011-07-31
IL182767A0 (en) 2007-09-20
CN101056641A (zh) 2007-10-17
ES2329815T3 (es) 2009-12-01
RU2007122391A (ru) 2008-12-20
EP1814555B1 (de) 2009-08-19
UA88655C2 (ru) 2009-11-10
SI1814555T1 (sl) 2009-12-31
PE20061051A1 (es) 2006-10-26
CA2587283C (en) 2013-01-15
TW200631584A (en) 2006-09-16
CA2587283A1 (en) 2006-05-18
MX2007005827A (es) 2007-07-20
AU2005303778B2 (en) 2011-02-17
AU2005303778A1 (en) 2006-05-18
RU2396957C2 (ru) 2010-08-20
WO2006051111A1 (en) 2006-05-18
NO20072285L (no) 2007-06-13
US20130225559A1 (en) 2013-08-29
US20070265245A1 (en) 2007-11-15
KR20070085470A (ko) 2007-08-27
PL1814555T3 (pl) 2010-01-29
RS51138B (sr) 2010-10-31
ATE439843T1 (de) 2009-09-15
JP2008519810A (ja) 2008-06-12
HK1104235A1 (en) 2008-01-11
US20100267694A1 (en) 2010-10-21
EP1814555A1 (de) 2007-08-08
CY1110538T1 (el) 2015-04-29
PT1814555E (pt) 2009-09-30
ZA200703884B (en) 2009-07-29
US20120302552A1 (en) 2012-11-29
BRPI0517818A2 (pt) 2010-03-16
CN102772414A (zh) 2012-11-14
NZ554858A (en) 2009-10-30
AR053780A1 (es) 2007-05-23
MY144089A (en) 2011-08-15
HRP20090513T1 (en) 2009-10-31
DK1814555T3 (da) 2009-12-07

Similar Documents

Publication Publication Date Title
DE602005026984D1 (de) Chinolin-derivate zur behandlung von latenter tuberkulose
DE602005007717D1 (de) Imidazolverbindungen zur behandlung von neurodegenerativen erkrankungen
ATE512663T1 (de) Kombination zur behandlung von erkrankungen mit zellproliferation
ATE429218T1 (de) Pinolensäure zur behandlung von übergewicht
ATE527241T1 (de) Pyridiazinonderivate zur behandlung von tumoren
ATE369333T1 (de) Sulfonamidderivate zur behandlung von krankheiten
ATE375977T1 (de) Sulfonamidderivate zur behandlung von krankheiten
DE602005023172D1 (de) Hydantoinderivate zur behandlung von entzündlichen erkrankungen
DE502005010499D1 (de) Implantat zur Behandlung von Fettsucht
DE602005019899D1 (de) System zur behandlung von ischämischem schlaganfall
DE602006019560D1 (de) 2-cyanobenzolsulfonamidverbindungen zur behandlung von samen
ATE493986T1 (de) Diarylharnstoffe zur behandlung von pulmonaler hypertonie
DE602004028763D1 (de) Te zur behandlung von virenerkrankungen
ATE521365T1 (de) Kinin-antagonisten zur behandlung von blasenfunktionsstörung
DE602005017503D1 (de) Biphenyloxyessigsäure - derivate zur behandlung von atemwegserkränkungen
DE602005016141D1 (de) S-mirtazapin zur behandlung von hitzewallungen
DE602006017367D1 (de) Amino-oxo-indolyliden-verbindungen zur verwendung in der behandlung von juckender kopfhaut
DE502004010131D1 (de) Pyridopyrimidinone zur behandlung von krebserkrankungen
DE602006003094D1 (de) 4-phenyl-5-oxo-1,4,5,6,7,8-hexahydrochinolin-derivate zur behandlung von unfruchtbarkeit
DE602006007323D1 (de) VERWENDUNG VON BAFF ZUR BEHANDLUNG Th2-INDUZIERTER LEIDEN
ATE504297T1 (de) Visnadin zur behandlung von kopfhautjucken
ATE526970T1 (de) Behandlung von mastitis
ATE503752T1 (de) Sulfamide alsendothelinrezeptorantagonsiten zur behandlung von herzkreislauferkrankungen
DE602005013287D1 (de) Zusammensetzung zur behandlung von leder
DE602005015434D1 (de) Mittel zur behandlung von psychoneurotischen krankheiten

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
R082 Change of representative

Ref document number: 1814555

Country of ref document: EP

Representative=s name: WUESTHOFF & WUESTHOFF PATENT- UND RECHTSANWAEL, DE